PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $741,000 | -72.3% | 18,495 | -74.2% | 0.00% | -50.0% |
Q1 2022 | $2,674,000 | -6.4% | 71,675 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $2,858,000 | +164.6% | 71,675 | +214.4% | 0.00% | +100.0% |
Q1 2021 | $1,080,000 | -22.6% | 22,800 | -0.3% | 0.00% | 0.0% |
Q4 2020 | $1,395,000 | +27.7% | 22,861 | -2.1% | 0.00% | 0.0% |
Q3 2020 | $1,092,000 | -56.3% | 23,353 | -52.6% | 0.00% | -66.7% |
Q2 2020 | $2,499,000 | -27.2% | 49,242 | -36.0% | 0.00% | -40.0% |
Q1 2020 | $3,431,000 | -49.4% | 76,902 | -45.5% | 0.01% | -16.7% |
Q4 2019 | $6,783,000 | +42.2% | 141,230 | +0.5% | 0.01% | +20.0% |
Q3 2019 | $4,771,000 | +15.1% | 140,462 | +52.5% | 0.01% | +25.0% |
Q2 2019 | $4,146,000 | +205.1% | 92,122 | +155.1% | 0.00% | +300.0% |
Q1 2019 | $1,359,000 | -48.9% | 36,114 | -53.9% | 0.00% | -66.7% |
Q4 2018 | $2,662,000 | +5.7% | 78,348 | +46.2% | 0.00% | +50.0% |
Q3 2018 | $2,518,000 | +34.3% | 53,585 | -3.6% | 0.00% | 0.0% |
Q2 2018 | $1,875,000 | +173.7% | 55,585 | +119.7% | 0.00% | +100.0% |
Q1 2018 | $685,000 | – | 25,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |